CRP and coronary artery disorder: Thus, a meta-analysis is needed for further insights into the association between TLR4 Asp299Gly and the CAD risk, the CRP level and the number of stenotic coronary arteries; and to investigate whether a synergistic effect between statin and 299Gly exists.